EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations

Hind Yassmine Chennai iD, Salah Belaidi iD, Lotfi Bourougaa iD, Mebarka Ouassaf iD, Leena Sinha iD, Abdelouahid Samadi iD, Samir Chtita iD

Molecules · 10.03.2024 · 29 (6) · 1232

DOI: 10.3390/molecules29061232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 10.03.2024. Verfasst von Hind Yassmine Chennai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, BP 145, Biskra 707000, Algeria. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Alzheimer Disease, Alkaloids, Sesquiterpenes. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huperzine A (HUP) plays a crucial role in Alzheimer’s therapy by enhancing cognitive function through increased cholinergic activity as a reversible acetylcholinesterase (AChE) inhibitor. Despite some limitations being seen in AChE inhibitors, ongoing research remains dedicated to finding innovative and more effective treatments for Alzheimer’s disease. To achieve the goal of the discovery of potential HUP analogues with improved physicochemical properties, less toxic properties, and high biological activity, many in silico methods were applied. Based on the acetylcholinesterase–ligand complex, an e-pharmacophore model was developed. Subsequently, a virtual screening involving a collection of 1762 natural compounds, sourced from the PubChem database, was performed. This screening yielded 131 compounds that exhibited compatibility with the established pharmacophoric hypothesis. These selected ligands were then subjected to molecular docking within the active site of the 4EY5 receptor. As a result, we identified four compounds that displayed remarkable docking scores and exhibited low free binding energy to the target. These top four compounds, CID_162895946, CID_44461278, CID_44285285, and CID_81108419, were submitted to ADMET prediction and molecular dynamic simulations, yielding encouraging findings in terms of their pharmacokinetic characteristics and stability. Finally, the molecular dynamic simulation, cross-dynamic correlation matrix, free energy landscape, and MM-PBSA calculations demonstrated that two ligands from the selected ligands formed very resilient complexes with the enzyme acetylcholinesterase, with significant binding affinity. Therefore, these two compounds are recommended for further experimental research as possible (AChE) inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAlzheimer DiseaseAlkaloidsSesquiterpenesHumansMolecular Dynamics SimulationMolecular Docking SimulationAcetylcholinesteraseLigands

Stichwörter der Autor:innen

ADMETAlzheimer’s diseaseHUPMM-PBSacetylcholinesterasedockinge-pharmacophoremolecular dynamics

Substanzen

Cholinesterase InhibitorsAcetylcholinesterasehuperzine ALigandsAlkaloidsSesquiterpenes

Autor:innen und Institutionen

  • Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, BP 145, Biskra 707000, Algeria.
  • Department of Physics, University of Lucknow, Lucknow 226010, India.
  • Department of Chemistry, College of Science, United Arab Emirates University (UAEU), Al Ain P.O. Box 15551, United Arab Emirates.
  • Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca 7955, Morocco.

ORCID-Profile: Hind Yassmine Chennai, Salah Belaidi, Lotfi Bourougaa, Mebarka Ouassaf, Leena Sinha, Abdelouahid Samadi, Samir Chtita

Förderung

  • United Arab Emirates University

Zitieren

APA

Chennai, H. Y., Belaidi, S., Bourougaa, L., Ouassaf, M., Sinha, L., Samadi, A., & Chtita, S. (2024). Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations. Molecules, 29(6), 1232. https://doi.org/10.3390/molecules29061232

Vancouver

Chennai HY, Belaidi S, Bourougaa L, Ouassaf M, Sinha L, Samadi A, et al. Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations. Molecules. 2024;29(6):1232. doi:10.3390/molecules29061232

BibTeX
@article{Chennai2024,
  author = {Chennai, Hind Yassmine and Belaidi, Salah and Bourougaa, Lotfi and Ouassaf, Mebarka and Sinha, Leena and Samadi, Abdelouahid and Chtita, Samir},
  title = {Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {6},
  pages = {1232},
  doi = {10.3390/molecules29061232}
}
Kostenlos starten →